Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Página 1 desde 173 resultados
Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to an anti-BMP9 (Bone morphogenetic protein-9) monoclonal antibody or an antibody fragment thereof binding to human BMP9, a hybridoma producing the antibody or the antibody fragment, a DNA encoding the antibody or
Anemia of cancer improving/prophylactic agent
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
CROSS REFERENCE TO RELATED APPLICATIONS
This is a national stage application based on PCT/JP2012/076020, filed on Oct. 5, 2012, which claims priority to Japanese Patent Application Nos. 2011-225383, filed on Oct. 12, 2011, and 2012-081346, filed on Mar. 30, 2012. This application claims the priority
Inhibition of DNA2 in fanconi anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Dec. 30, 2014, is named SEQLISTING75729.txt and is 628 bytes in size.
BACKGROUND
Fanconi
Pharmaceutical composition for the treatment of the anemia of malignant tumors
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The present invention relates to a pharmaceutical composition for the treatment of the anemia of malignant tumors that comprises a therapeutically effective amount of human erythropoietin (hereinafter referred to as "human EPO") in a parenterally acceptable vehicle.
The term "human EPO" as used
Pharmaceutical composition of BUF-5 for treating anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION
FIELD OF THE INVENTION
The present invention relates to pharmaceutical compositions containing as an effective ingredient, at least one substance selected from the polypeptides BUF-4 and BUF-5 (hereafter referred to as BUF-4 and BUF-5), more particularly, to
Compositions and methods for therapy and prevention of cancer, AIDS, and anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
II. FIELD OF THE INVENTION
This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives as antitumor, and antiviral agents, and treatment of severe beta-chain hemoglobinopathies.
III. BACKGROUND OF THE INVENTION
Some of the most dreadful epidemics,
Anti-IL-6 antibodies for the treatment of anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
IL-6 antagonists, including anti-IL-6 antibodies and antigen-binding fragments thereof, may be used to reduce C-reactive protein ("CRP levels") and inflammation and in methods and compositions for the treatment and prevention of anemia, including anemia associated with
Methods of treating anemia using anti-IL-6 antibodies
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The sequence listing in the file named "67858o707001v3.txt" having a size of 342,545 bytes that was created Jun. 13, 2012 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is an extension of Applicants' prior invention disclosed
Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
I. FIELD OF THE INVENTION
This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer
Compositions and methods for therapy and prevention of pathologies including cancer, AIDS, and anemia
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
I. FIELD OF THE INVENTION
This invention relates to methods of using phenylacetic acid and its pharmaceutically acceptable derivatives to treat and prevent pathologies and to modulate cellular activities. In particular, this invention relates to A) phenylacetate and its derivatives in cancer
Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
1. Field of the Invention
The field of the invention is generally related to methods of treating anemia with an agent capable of blocking, inhibiting, or ameliorating vascular endothelial growth factor (VEGF).
2. Description of Related Art
The production of red blood cells in mammals,
Treating anemia in subjects by administration of plasmids encoding growth hormone releasing hormone
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND
The present invention pertains to compositions and methods for plasmid-mediated supplementation. The present invention pertains to compositions and methods that are useful for retarding the growth rate of abnormal cells, tumor progression reduction, prevention of kidney failure, reduction
Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention is directed to a new use for Erythropoetin ("EPO"), such as EPO alpha, for treating hepatitis C and/or anemia caused by hepatitis C treatment. Accordingly, the invention involves using EPO with hepatitis C treatment, such as Ribavirin ("RBV") and/or
Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF THE INVENTION
The present invention is directed to a new use for Erythropoetin ("EPO"), such as EPO alpha, for treating hepatitis C and/or anemia caused by hepatitis C treatment. Accordingly, the invention involves using EPO with hepatitis C treatment, such as Ribavirin ("RBV") and/or
Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
The present invention relates to novel proteins and/or polypeptides of the Chicken Anemia Virus. Besides, it relates to vaccines and compositions for preventing or treating virus infections in poultry, in particular infections with the Chicken Anemia Virus (CAV).
In particular, the invention relates
La base de datos de hierbas medicinales más completa respaldada por la ciencia
- Funciona en 55 idiomas
- Curas a base de hierbas respaldadas por la ciencia
- Reconocimiento de hierbas por imagen
- Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
- Leer publicaciones científicas relacionadas con su búsqueda
- Buscar hierbas medicinales por sus efectos.
- Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.
Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.
